B&L Seeks Preliminary Approval of $40 Million Immunomedics Settlement

Proposed settlement comes after four years of intense litigation.

Block & Leviton today filed a motion seeking preliminary approval of a $40 million settlement in the long-running securities case against Immunomedics (which has since been acquired) and its executives. Additional details about the settlement are available on the case website.

Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.

January 20, 2023

More News Stories

December 29, 2022
Kim Evans to Speak at PLI's 2023 M&A Conference

Speakers include members of the Delaware bench

Read story
December 21, 2022
Securities Sidebar: December 2022

Block & Leviton's winter newsletter.

Read story
July 18, 2022
Block & Leviton Announces Kimberly A. Evans To Lead Firm's Delaware Office

Ms. Evans is replacing Nathan A. Cook, who was recently confirmed as the next Vice Chancellor of the Delaware Court of Chancery.

Read story